课题基金 / 基金详情

Improving the Precision of Genetic Markers for Psychotic Disorders

Improving the Precision of Genetic Markers for Psychotic Disorders
提高精神障碍遗传标记的精确度
批准号:
10574617
负责人:
Katherine G Jonas
金额:
$16.93万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-05 至 2024-10-31
关键词:
AccountingAffectAnhedoniaAttenuatedBasic ScienceBiologicalBiological MarkersBipolar DisorderClinicalCommunicationCountyDataDelusionsDevelopmentDiagnosisDiagnosticDimensionsDiseaseEnvironmentEtiologyEvaluationExerciseFeeling suicidalFundingFutureGene Expression ProfileGeneticGenetic MarkersGenetic Predisposition to DiseaseGenetic RiskGenetic StructuresGenomicsHallucinationsHealthHeritabilityImpairmentIndividualInterventionInvestigationKnowledgeLongitudinal cohortLongitudinal cohort studyLongterm Follow-upManicMental HealthMental disordersMethodsModelingMoodsNational Institute of Mental HealthOutcomeParticipantPathway interactionsPatientsPersonsPharmaceutical PreparationsPhenotypePrognosisPrognostic MarkerPsychiatryPsychopathologyPsychosesPsychotic DisordersResearchResearch Domain CriteriaResearch PersonnelResourcesRiskRisk BehaviorsRunningSamplingSchizophreniaSeverity of illnessSignal TransductionSleepSourceSpecificityStatistical MethodsSumSymptomsTechnologyTestingTrainingTraining ProgramsTranslational ResearchTreatment outcomeUnited StatesUnited States National Institutes of HealthVariantWeightbiomarker validationburden of illnesscareerclinical applicationclinical candidateclinical careclinical translationclinically significantcohortdepressive symptomsdisorder riskethnic diversityfirst episode psychosisfollow-upfunctional outcomesgenetic variantimprovednovelpleiotropismpolygenic risk scorepsychosis riskpsychosocialpsychoticresponsible research conductsevere mental illnesssimulationsymptomatologytooltreatment response

项目摘要

项目成果

Katherine G Jonas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Psychotic disorders account for more than 10% of mental-health-related disease burden in the United States, but it remains difficult to predict who will develop a psychotic disorder, how their illness will progress, and how they will respond to available treatments. Recent findings suggest promise for genetic markers for psychotic illnesses, but these tools are imprecise, limiting their utility for basic research and clinical application. This K08 application outlines a research and training program that will support the applicant's development towards an NIH-funded, independent research career investigating the genetic liabilities for serious mental illness. The activities outlined in this application build on the candidate's clinical and quantitative background, and through training exercises set in a resource-rich environment, facilitate the development of expertise in 1) scientific communication and responsible conduct of research; 2) statistical genetics, 3) genetics of psychotic disorders, and 4) translational research for evaluating genetic markers for clinical applications. The aim of the research outlined in this proposal is to validate a novel method of identifying polygenic risk for psychotic disorders that takes account of overlapping symptoms and common genetic vulnerabilities. This approach aims to improve the precision of polygenic risk scores. This method will be applied in an ethnically diverse sample of 30,000 individuals with psychotic disorders, identifying polygenic risk scores for both general and specific facets of psychotic symptomatology. The resulting risk scores will be validated in pooled analysis of nine longitudinal cohort studies, comprising 1,785 cases. Risk scores will be tested as predictors of psychosis onset, diagnosis, symptom trajectory, psychosocial outcomes, and treatment response. If the proposed research succeeds in identifying genetic correlates of specific dimensions of psychotic disorders that predict these important health outcomes, it will have important implications for etiological research, as it may help to identify targets for intervention. The findings would also have significance for clinical translational research, as genetic markers have potential application as aids in diagnosis and prognosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving the Precision of Genetic Markers for Psychotic Disorders
Optimized Phenotypes for Genetic Association Studies
海外基金